Debut Plus

₹7.88

▲ +0.12 +1.55%

17 Jul 2026

NSE Listed

ESM 1

Vaishali Pharma Limited (VAISHALI)

Volume: 76,970Avg Vol 1W: 1,20,375Avg Vol 1M: 79,064.5552W Range:₹4.75₹13.59
NSE BSE www.vaishalipharma.com
Key Ratios
Checked 18h ago
Market Cap₹101 Cr
Current Price₹7.88
Previous Close₹7.76
High / Low (52w)₹13.59 / ₹4.75
Volume76,970
Avg Vol (1W)1,20,375
Avg Vol (1M)79,064.55
Stock P/E258.67
Book Value₹5.3
Dividend Yield0%
ROE6.03%
ROA328.2%
Revenue (TTM)₹102 Cr
Revenue Growth—
Profit Margin386.1%
Total Debt₹19 Cr
Shares Outstanding13 Cr
Face Value₹1
EPS (TTM)₹0.32
P/B1.46
Debt / Equity0.24
50 DMA₹7.27
200 DMA₹8.07
Day change+1.55%
SurveillanceESM 1 (as of 2026-07-15)
Price Chart
₹7.88▼ 38.87% · 1Y
₹13₹533.8L
2025-07-16
2026-07-15

20-day avg volume: 79K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 259.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹18 Cr₹21 Cr₹28 Cr₹32 Cr₹24 Cr₹33 Cr₹25 Cr₹27 Cr
EBITDA₹3 Cr₹3 Cr₹2 Cr₹-5 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr
Net Profit₹2 Cr₹2 Cr₹1 Cr₹-4 Cr₹1 Cr₹1 Cr₹1 Cr₹0 Cr
EPS1.381.510.98-0.330.1———
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹69 Cr₹77 Cr₹62 Cr₹56 Cr₹78 Cr₹72 Cr₹88 Cr₹102 Cr
EBITDA₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹8 Cr₹11 Cr₹3 Cr₹3 Cr
Net Profit₹1 Cr₹1 Cr₹0 Cr₹1 Cr₹4 Cr₹7 Cr₹1 Cr₹1 Cr
EPS1.410.680.030.993.825.910.640.06
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹64 Cr₹69 Cr₹66 Cr₹86 Cr₹82 Cr₹79 Cr₹80 Cr₹110 Cr
Total Liabilities₹44 Cr₹47 Cr₹45 Cr₹64 Cr₹55 Cr₹38 Cr₹37 Cr₹45 Cr
Equity₹21 Cr₹21 Cr₹21 Cr₹22 Cr₹26 Cr₹41 Cr₹43 Cr₹65 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹-18 Cr
Investing₹0 Cr₹-1 Cr₹0 Cr₹1 Cr₹0 Cr
Financing₹-2 Cr₹0 Cr₹-2 Cr₹-1 Cr₹18 Cr
Free Cash Flow₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹-18 Cr
Shareholding
Promoter 30.54% Institutions 0% Public 69.46%
Efficiency & Working Capital
ROCE8.4%
Interest Coverage1.6
Dividend Payout—
Debtor Days172 d
Inventory Days18 d
Payable Days100 d
Cash Conversion Cycle90 d
Working Capital Days190 d
Shareholding Details

As of 2026-07-31

Promoter30.5%
FII0%
DII0%
Institutions0%
Public69.5%
Promoter Pledge0%
No. of Shareholders26,697
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMay 2024Jun 2024Jul 2024Jul 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jul 2026
Promoters24.9%26.3%31.6%31.6%26.3%26.3%26.3%26.3%26.3%31.6%31.6%30.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public75.1%73.7%68.4%68.4%73.7%73.7%73.7%73.7%73.7%68.4%68.4%69.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders10,2979,4799,4799,47918,98327,54628,87428,68227,75227,14826,53426,697
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Atul Arvindbhai VasaniShareholding of Promoter and Promoter Group23.1%3.11 Cr
Sapan Anil ShahPublic Shareholding6.2%83,25,921
Jagruti Atul VasaniShareholding of Promoter and Promoter Group5%67,99,920
Kesar Pharma LimitedPublic Shareholding3.4%45,37,865
Nupur Anil ShahPublic Shareholding3.2%42,72,592
Renu PittiePublic Shareholding1.7%22,69,025
Sonal Sanjay MiraniPublic Shareholding1.5%20,46,710
Sanjay Girdharilal MiraniPublic Shareholding1.5%20,00,000
Kirit Chimanlal ToliaPublic Shareholding1.3%17,00,000
Priyanka Atul VasaniShareholding of Promoter and Promoter Group0.7%10,00,010
Dewansh Ajay VasaniShareholding of Promoter and Promoter Group0.7%10,00,010
Bharti Kiritkumar ToliaShareholding of Promoter and Promoter Group0.5%7,20,000
Kevin Atul VasaniShareholding of Promoter and Promoter Group0.4%5,00,010
Punita Kaushik GandhiShareholding of Promoter and Promoter Group0%39,770
Vaishali A VasaniShareholding of Promoter and Promoter Group0%35,320
Aneree Ajay VasaniShareholding of Promoter and Promoter Group0%10
Ajay Arvindbhai VasaniShareholding of Promoter and Promoter Group0%10
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Atul Arvindbhai Vasani00%2026-07-03
Vaishali A Vasani00%2026-07-03
Jagruti Atul Vasani00%2026-07-03
Bharti Kiritkumar Tolia00%2026-07-03
Punita Kaushik Gandhi00%2026-07-03
Ajay Arvindbhai Vasani00%2026-07-03
Priyanka Atul Vasani00%2026-07-03
Dewansh Ajay Vasani00%2026-07-03
Aneree Ajay Vasani00%2026-07-03
Kevin Atul Vasani00%2026-07-03
Sanjay Girdharilal Mirani00%2026-07-03
Nupur Anil Shah00%2026-07-03
Board of Directors
NameDesignationYear
Atul VasaniChairman / Executive Director / M D / Promoter2025
Pratik Vikram JakheliaIndependent Non Exe. Director2025
Manish Bhagwandas VedIndependent Non Exe. Director2025
Dewansh VasaniExecutive Director & CFO2025
Jagruti VasaniWTD & Executive Director2025
Bhaveshkumar Popatlal UpadhyayIndependent Non Exe. Director2025
Vishwa MekhiaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Marketing of Pharmaceutical Product₹0 Cr—
Segments — Geography
RegionRevenueShare
Domestic₹68 Cr69.4%
Exports₹30 Cr30.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹2272626
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-08Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000505
2025000303
2025000000
Company Information
Incorporated2008
ChairmanAtul Vasani
AuditorRaman S Shah & Associates
Investor Email[email protected]
🌐 www.vaishalipharma.com ↗

📍 706 to 709 7th Floor Aravali, Business Centre Borivali(W), Mumbai, Maharashtra, 400092

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Uttam Sugar Mills Ltd.Ultra Wiring Conn Sys Ltd.U. Y. Fincorp LimitedV2 Retail LimitedVadilal Industries Ltd.Vaibhav Global LimitedVakrangee LimitedValiant Laboratories Ltd.Valiant Organics LimitedValue 360 Communication LimitedVedanta Aluminium Metal LimitedVardhaman Acrylics Ltd.All “V” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search